Anti-HLA-G Biotin
CAT:
270-1B-291-C025
Size:
0.025 mg
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No

Anti-HLA-G Biotin
- CAS Number: 9007-83-4
- Clone: MEM-G/1
- Format: Biotin
- Buffer: Phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide
- References & Citations: *Amiot L, Vu N, Rauch M, Helgoualc'h AL, Chalmel F, Gascan H, Turlin B, Guyader D, Samson M: Expression of HLA-G by mast cells is associated with hepatitis C virus-induced liver fibrosis. J Hepatol. 2013 Sep 11. pii: S0168-8278(13), URL: http://www.ncbi.nlm.nih.gov/pubmed/?term=amiot+l+vu+n+rauch+m ,*Hurks HM, Valter MM, Wilson L, Hilgert I, van den Elsen PJ, Jager MJ: Uveal melanoma: no expression of HLA-G. Invest Ophthalmol Vis Sci. 2001 Dec42(13):3081-4., URL: https://www.ncbi.nlm.nih.gov/pubmed/11726606?ordin,*Gonen-Gross T, Achdout H, Arnon TI, Gazit R, Stern N, Horejsí V, Goldman-Wohl D, Yagel S, Mandelboim O: The CD85J/leukocyte inhibitory receptor-1 distinguishes between conformed and beta 2-microglobulin-free HLA-G molecules. J Immunol. 2005 Oct 15175(8):4866-74., URL: https://www.ncbi.nlm.nih.gov/pubmed/16210588?ordin,*Shih IM, Kurman RJ: p63 expression is useful in the distinction of epithelioid trophoblastic and placental site trophoblastic tumors by profiling trophoblastic subpopulations. Am J Surg Pathol. 2004 Sep28(9):1177-83., URL: https://www.ncbi.nlm.nih.gov/pubmed/15316317?dopt=,*Boyson JE, Erskine R, Whitman MC, Chiu M, Lau JM, Koopman LA, Valter MM, Angelisova P, Horejsi V, Strominger JL: Disulfide bond-mediated dimerization of HLA-G on the cell surface. Proc Natl Acad Sci U S A. 2002 Dec 1099(25):16180-5. Epub 2002 Nov 26., URL: https://www.ncbi.nlm.nih.gov/pubmed/12454284?dopt=,*Frumento G, Franchello S, Palmisano GL, Nicotra MR, Giacomini P, Loke YW, Geraghty DE, Maio M, Manzo C, Natali PG, Ferrara GB: Melanomas and melanoma cell lines do not express HLA-G, and the expression cannot be induced by gammaIFN treatment. Tissue Antigens. 2000 Jul56(1):30-7., URL: https://www.ncbi.nlm.nih.gov/pubmed/10958353?dopt=,*Fournel S, Huc X, Aguerre-Girr M, Solier C, Legros M, Praud-Brethenou C, Moussa M, Chaouat G, Berrebi A, Bensussan A, Lenfant F, Le Bouteiller P: Comparative reactivity of different HLA-G monoclonal antibodies to soluble HLA-G molecules. Tissue Antigens. 2000 Jun55(6):510-8., URL: https://www.ncbi.nlm.nih.gov/pubmed/10902607?dopt=,*Zhang X, Lin A, Han QY, Zhang JG, Chen QY, Ye YH, Zhou WJ, Xu HH, Gan J, Yan WH: Intratumor heterogeneity of HLA-G expression in cancer lesions. Front Immunol. 2020 Nov 1911:565759., URL: https://pubmed.ncbi.nlm.nih.gov/33329527/,*Swets M, Wouters A, Krijgsman D, van Vlierberghe RL, Boot A, van Eendenburg JD, van Wezel T, Gelderblom H, van de Velde CJ, van den Elsen PJ, Kuppen PJ: HLA-G protein expression in colorectal cancer evaluated by immunohistochemistry and Western blot analysis: Its expression characteristics remain enigmatic. Clin Immunol. 2018 Sep194:80-86., URL: https://pubmed.ncbi.nlm.nih.gov/30006120/,*Menier C, Saez B, Horejsi V, Martinozzi S, Krawice-Radanne I, Bruel S, Le Danff C, Reboul M, Hilgert I, Rabreau M, Larrad ML, Pla M, Carosella ED, Rouas-Freiss N: Characterization of monoclonal antibodies recognizing HLA-G or HLA-E: new tools to analyze the expression of nonclassical HLA class I molecules. Hum Immunol. 2003 Mar64(3):315-26., URL: https://pubmed.ncbi.nlm.nih.gov/12590976/,*Lodererová A, Honsová E, Viklický O: Detection of HLA-G on human extravillous cytotrophoblast and skeletal muscle with a new monoclonal antibody MEM-G/1. Folia Microbiol. (Praha) 200348(2):239-42., URL: https://pubmed.ncbi.nlm.nih.gov/12800509/,
- Other References: *Creput C, Durrbach A, Menier C, Guettier C, Samuel D, Dausset J, Charpentier B, Carosella ED, Rouas-Freiss N. Human leukocyte antigen-G (HLA-G) expression in biliary epithelial cells is associated with allograft acceptance in liver-kidney transplantation. J Hepatol. 2003 39(4):587-94., URL: https://pubmed.ncbi.nlm.nih.gov/12971970/,*Menier C, Saez B, Horejsi V, Martinozzi S, Krawice-Radanne I, Bruel S, LeDanff C, Reboul M, Hilgert I, Rabreau M, Larrad ML, Pla M, Carosella ED, Rouas-Freiss N: Characterization of monoclonal antibodies recognizing HLA-G or HLA-E: new tools to analyze the expression of nonclassical HLA class I molecules. Hum Immunol. 2003 64(3):315-26., URL: https://pubmed.ncbi.nlm.nih.gov/12590976/,*Lin A, Yan WH: Heterogeneity of HLA-G expression in cancers: Facing the challenges. Front Immunol. 2018 Sep 279:2164., URL: https://pubmed.ncbi.nlm.nih.gov/30319626/,*Hunt JS, Langat DK, McIntire RH, Morales PJ: The role of HLA-G in human pregnancy. Reprod Biol Endocrinol. 20064 Suppl 1(Suppl 1):S10., URL: https://pubmed.ncbi.nlm.nih.gov/17118165/,*Xu HH, Yan WH, Lin A: The role of HLA-G in human papillomavirus infections and cervical carcinogenesis. Front Immunol. 2020 Jun 2511:1349., URL: https://pubmed.ncbi.nlm.nih.gov/32670296/,*Castelli EC, de Almeida BS, Muniz YC, Silva NS, Passos MR, Souza AS, Page AE, Dyble M, Smith D, Aguileta G, Bertranpetit J, Migliano AB, Duarte YA, Scliar MO, Wang J, Passos-Bueno MR, Naslavsky MS, Zatz M, Mendes CT, Donadi EA: HLA-G genetic diversity and evolutive aspects in worldwide populations. Sci Rep. 2021 Nov 2911(1):23070., URL: https://pubmed.ncbi.nlm.nih.gov/34845256/,*Curigliano G, Criscitiello C, Gelao L, Goldhirsch A: Molecular pathways: Human leukocyte antigen G (HLA-G). Clin Cancer Res. 2013 Oct 1519(20):5564-71., URL: https://pubmed.ncbi.nlm.nih.gov/23897901/,